ProShare Advisors’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.39M Sell
12,712
-3,254
-20% -$881K 0.01% 623
2025
Q4
$4.01M Buy
15,966
+1,227
+8% +$326K 0.01% 603
2025
Q3
$4.23M Sell
14,739
-154
-1% -$41.3K 0.01% 578
2025
Q2
$3.91M Buy
14,893
+1,677
+13% +$408K 0.01% 591
2025
Q1
$3.08M Buy
13,216
+544
+4% +$132K 0.01% 605
2024
Q4
$2.91M Buy
12,672
+1,342
+12% +$308K 0.01% 623
2024
Q3
$2.53M Sell
11,330
-931
-8% -$205K 0.01% 646
2024
Q2
$2.5M Buy
12,261
+807
+7% +$164K 0.01% 630
2024
Q1
$2.5M Sell
11,454
-299
-3% -$65.9K 0.01% 634
2023
Q4
$2.67M Sell
11,753
-1,729
-13% -$363K 0.01% 615
2023
Q3
$2.71M Sell
13,482
-2,906
-18% -$613K 0.01% 598
2023
Q2
$3.4M Buy
16,388
+499
+3% +$96.8K 0.01% 578
2023
Q1
$3.13M Buy
15,889
+1,909
+14% +$393K 0.01% 588
2022
Q4
$2.83M Sell
13,980
-372
-3% -$72.7K 0.01% 557
2022
Q3
$2.53M Sell
14,352
-2,015
-12% -$413K 0.01% 572
2022
Q2
$3.29M Sell
16,367
-6,538
-29% -$1.39M 0.01% 565
2022
Q1
$5.19M Sell
22,905
-1,318
-5% -$310K 0.01% 545
2021
Q4
$6.54M Buy
24,223
+5,249
+28% +$1.3M 0.01% 518
2021
Q3
$4.59M Sell
18,974
-643
-3% -$162K 0.01% 534
2021
Q2
$4.65M Buy
19,617
+3,208
+20% +$731K 0.01% 512
2021
Q1
$3.6M Buy
16,409
+832
+5% +$167K 0.01% 530
2020
Q4
$2.72M Buy
15,577
+1,550
+11% +$268K 0.01% 564
2020
Q3
$2.27M Buy
14,027
+454
+3% +$72K 0.01% 541
2020
Q2
$1.94M Buy
13,573
+1,815
+15% +$251K 0.01% 566
2020
Q1
$1.28M Sell
11,758
-8,110
-41% -$1.17M 0.01% 552
2019
Q4
$2.89M Buy
19,868
+3,969
+25% +$573K 0.01% 542
2019
Q3
$2.29M Buy
15,899
+850
+6% +$124K 0.01% 560
2019
Q2
$2.23M Sell
15,049
-2,907
-16% -$406K 0.01% 564
2019
Q1
$2.36M Buy
17,956
+441
+3% +$54.3K 0.01% 565
2018
Q4
$1.9M Buy
17,515
+906
+5% +$121K 0.01% 583
2018
Q3
$2.48M Sell
16,609
-1,580
-9% -$240K 0.02% 560
2018
Q2
$2.81M Sell
18,189
-1,242
-6% -$187K 0.02% 559
2018
Q1
$2.7M Buy
19,431
+474
+3% +$69.6K 0.02% 558
2017
Q4
$2.6M Buy
18,957
+5,503
+41% +$727K 0.02% 551
2017
Q3
$1.75M Buy
13,454
+1,836
+16% +$245K 0.02% 592
2017
Q2
$1.54M Sell
11,618
-407
-3% -$49.8K 0.02% 625
2017
Q1
$1.48M Buy
12,025
+80
+0.7% +$9.47K 0.02% 638
2016
Q4
$1.32M Buy
11,945
+2,345
+24% +$261K 0.01% 667
2016
Q3
$1.13M Sell
9,600
-16,298
-63% -$1.92M 0.02% 644
2016
Q2
$2.9M Sell
25,898
-865
-3% -$93.1K 0.04% 367
2016
Q1
$2.69M Buy
26,763
+6,054
+29% +$580K 0.04% 368
2015
Q4
$2.2M Buy
20,709
+1,167
+6% +$120K 0.03% 476
2015
Q3
$1.82M Buy
19,542
+881
+5% +$91.1K 0.03% 496
2015
Q2
$1.94M Sell
18,661
-3,185
-15% -$332K 0.03% 530
2015
Q1
$2.37M Buy
21,846
+1,699
+8% +$175K 0.03% 515
2014
Q4
$1.87M Buy
20,147
+3,041
+18% +$269K 0.02% 578
2014
Q3
$1.5M Sell
17,106
-1,689
-9% -$153K 0.02% 885
2014
Q2
$1.65M Sell
18,795
-1,847
-9% -$160K 0.02% 893
2014
Q1
$1.74M Buy
20,642
+1,091
+6% +$87K 0.02% 849
2013
Q4
$1.53M Buy
19,551
+9,224
+89% +$787K 0.02% 852
2013
Q3
$880K Sell
10,327
-7,592
-42% -$639K 0.02% 971
2013
Q2
$1.54M Buy
+17,919
New +$1.49M 0.03% 589

Other funds holding LH

ProShare Advisors's LH Position: Q1 2026 in Review

ProShare Advisors reduced its Labcorp (LH) stake by 20% in Q1 2026, selling an estimated $881K and leaving 12,712 shares worth $3.39M. The position accounts for 0.01% of the portfolio, ranked #623.

ProShare Advisors first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.54M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • ProShare Advisors held 12,712 shares of Labcorp worth $3.39M as of Q1 2026.
  • ProShare Advisors sold 3,254 Labcorp shares in Q1 2026, an estimated $881K.
  • Labcorp made up 0.01% of ProShare Advisors's portfolio in Q1 2026, its #623 holding.
  • ProShare Advisors first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • ProShare Advisors's Labcorp position peaked at $6.54M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.